Ciclobendazole

Ciclobendazole
Clinical data
ATC code	P02CA04 (WHO) ;
Identifiers
	IUPAC name Methyl N-[6-(cyclopropanecarbonyl)-1H-benzimidazol-2-yl]carbamate;
CAS Number	31431-43-3 ;
PubChem CID	35803;
ChemSpider	32933 ;
UNII	JF3KQ40J31;
KEGG	D03623 ;
CompTox Dashboard (EPA)	DTXSID9057713 ;
ECHA InfoCard	100.046.018
Chemical and physical data
Formula	C13H13N3O3
Molar mass	259.265 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES COC(=O)Nc3nc2ccc(C(=O)C1CC1)cc2[nH]3;
	InChI InChI=1S/C13H13N3O3/c1-19-13(18)16-12-14-9-5-4-8(6-10(9)15-12)11(17)7-2-3-7/h4-7H,2-3H2,1H3,(H2,14,15,16,18) ; Key:OXLKOMYHDYVIDM-UHFFFAOYSA-N ;
	(what is this?) (verify)

Ciclobendazole is an anthelmintic, that is a pharmaceutical drug against parasitic worms. It underwent a clinical trial in the 1970s, where it was found to be as effective as mebendazole in the treatment of hookworm infection and ascariasis, but significantly less effective in the treatment of trichuriasis.[1]

It is not known to be marketed anywhere in the world.[2]

References

Guggenmoos R, Akhtaruzzaman KM, Rosenkaimer F, Gaus W, Bienzle U, Dietrich M (December 1978). "Comparative trial on the therapeutic effectiveness of the new anthelmintic drug: ciclobendazole". Tropenmedizin und Parasitologie. 29 (4): 423–6. PMID 369076.
"Ciclobendazole search results". Drugs.com. Retrieved 2021-03-31.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.